NZeno
New Zealand, NZ · 4 known investors
NZeno develops genetically edited pig kidneys for human transplantation to address the shortage of donor organs for patients with End Stage Renal Disease. The company uses gene editing technology to eliminate immune rejection factors in New Zealand-bred pigs.
BiotechMedical Devices